In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BASF SE

www.basf.com

Latest From BASF SE

Need Private Meeting For Sunscreen MUsT Details? Just Ask, FDA Says

"FDA meetings with an individual manufacturer regarding inclusion of ingredients in the monograph ... could have broad applicability, and hence are generally public," CDER says. But, "regulations permit any person to request a private meeting, and FDA will make reasonable efforts to accommodate such requests."

OTC Drugs FDA

FDA 'May Hold Private Meetings' Offer Eases Sunscreen Monograph Tension

Proposed final sunscreen monograph published in February provided more clarity for TEA sponsors to engage with agency, but May publication of final guidance on MUsT for topically applied ingredients for OTC drug monograph could motivate TEA sponsors for sunscreen and other topical active ingredients to push their proposals forward.

OTC Drugs Cosmetics

IPA's Jain On The Journey So Far And Fires To Douse

Sudarshan Jain, the new secretary general of the Indian Pharmaceutical Alliance and ex-Abbott managing director, wears many hats, including that of a senior advisor with a private equity advisory firm. He recounts having “survived in different cultures” in his career and outlines the priorities in his new role, amid continuing questions around generic quality.

India Commercial

Industry, NGOs Still Divided On Alternative Testing With EU Ingredient Innovation Stalled

Animal groups continue to call for a global ban on cosmetic animal testing while Cosmetics Europe advises outside jurisdictions to be prudent about prohibitions, noting that ingredient innovation has grinded to a halt in the EU in recent years. There does seem to be growing agreement between the camps that alternative methods are making important progress and show great promise compared with traditional standards.

Cosmetic Ingredients Regulation
See All

Company Information

  • Industry
  • Diversified
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • BASF AG
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • BASF SE
  • Senior Management
  • Jurgen Hambrecht, Chmn. & CEO
    Kurt Bock, CFO
  • Contact Info
  • BASF SE
    Phone: (49) 0621 600
    Carl-Bosch-Strasse 38
    Ludwigshafen, 67056
    Germany
UsernamePublicRestriction

Register